Copyright
©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 103854
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103854
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103854
Table 1 The production pathways of different short-chain fatty acids
| Related microorganisms | Way | Mechanism of action | |
| Acetate[5,25,26,29,84,94] | Holdemanella | Acetyl-CoA pathway | (1) Improve mitochondrial modification and activate AMP-activated protein kinase to enhance fat oxidation[23]; (2) Activate GPR43 receptor[27]; and (3) Provide energy for organisms and synthesize cholesterol and lipids[26] |
| F. prausnitzii | |||
| Lachnospiraceae | |||
| Ruminococcus | |||
| Bifidobacterium | |||
| Bacteroides | |||
| Streptococcus | |||
| Clostridum | The Wood-ljungdahl pathway | ||
| Propionate[5,22,25,26,84,94,95] | F. prausnitzii | Succinate pathway and acrylate pathway | (1) Enhance fatty-acid oxidation and reduce hepatic lipid accumulation[15]; (2) Activate GPR43 and GPR41 receptors[28]; and (3) Participate in the regulatory metabolism of gluconeogenesis[26] |
| Prevotella | |||
| Bacteroides | |||
| Megasphaera elsdenii | |||
| Dalister succinatiphilus | |||
| Ruminococcus | |||
| Veillonella | |||
| Phascolarctobacterium | |||
| Coprococcus | |||
| Roseburia | Propylene glycol pathway | ||
| Salmonella | |||
| Akkermansia municiphilla | |||
| Butyrate[15,22,25,26,84,95,96] | Eubacteriota | Acetyl-coa pathway | (1) The energy source for the intestinal mucosa, promote the expression of tight junction proteins, and prevent "intestinal leakage"[97]; (2) Reduce the secretion of pro-inflammatory factors[25]; (3) Induce fat oxidation and attenuate the activation of HSC[16,36,37]; and (4) Activate GPR43 and GPR41 receptors[28] |
| Clostridial cluster IV and XIVa | |||
| Dalister succinatiphilus | |||
| Oscillibacter | |||
| Dorea | |||
| F. prausnitzii | |||
| Roseburia spp | |||
| Ruminococcus | |||
| Eubacterium rectale | |||
| Coprococcus | Phosphotransbutyrylase/butyrate kinase pathway | ||
| Anaerobutyricum | |||
| Subdoligranulum | |||
| Roseburia |
Table 2 Probiotics regulate the gut microbiota and related disease factors
| Probiotics | Phylum (Gram negative/positive) | Changes | Function |
| Bacillus subtilis + Enterococcus faecium[78] | Firmicutes (G+) | Firmicutes/Bacteroidetes↓ | IL-1β, IL-6, TNF-α↓ |
| Akkermansia, Ruminococcus_UCG-014, Eubacterium_coprostanoligenes_group↑ | TLR4, NF-κB↓ | ||
| Lachnoclostridium, Oscillibacter, Family_XIII_AD3011_group, Anaerovorax, Acetatifactor, Coriobacterium_UCG-002, Negativibacillus, Angelakisella, Ruminococcus, Harryflintia, Escherichia-Shigella↑ | LPS↓ | ||
| Lactobacillus acidophilus KLDS1.0901[77] | Firmicutes (G+) | Roseburia, Lachnospiraceae UCG-006, Bacteroides, Enterorhabdus↓ | IL-1β, IL-6, TNF-α, LPS, Lactic acid↓ |
| Blautia, Alistipes, Oscillibacter, Faecalibaculum, Ruminiclostridium, Lactobacillus, Ruminococcaceae UCG-009↑ | IL-10↑ | ||
| Lactobacillus plantarum NCU116[76] | Firmicutes (G+) | Allobaculum, Lactobacillus, Bifidobacterium↑ | LPS↓ |
| Intestinal barrier intact | |||
| Bifidobacterium longum MG723, MG731[76] | Actinobacteria (G+) | F4/80, MCP-1, TGF-β, IL-1β, IL-18↓ | |
| BAs↑ | |||
| Bifidobacterium lactis, Bifidobacterium.longum DD98[76] | Actinobacteria (G+) | IL-6, IL-1β, TNF-α↓ | |
| Bifidobacterium longum R0175[76] | Actinobacteria (G+) | Alloprevotella spp.↑ | IL-1, TNF-α, Chemokines↓ |
| Acetatifactor muris, Butyricimonas spp., Oscillibacter spp.↓ | |||
| Bifidobacterium longum LC67[76] | Actinobacteria (G+) | Firmicutes, Proteobacteria, Tyzzerella, Escherichia-Shigella, Nestiinimonas, Osillibacter, Ruminiclostridium↓ | |
| Faecalibacterium, Lactobacillus↑ | |||
| Bifidobacterium bifidum[76] | Actinobacteria (G+) | Tyzzerella, Escherichia-Shigella, Nestiinimonas, Osillibacter↓ | Propionate, butyrate↑ |
| Faecalibacterium, Ruminococcus↑ | |||
| Lactobacillus paracasei Jlus66[98] | Actinobacteria (G+) | Firmicutes↑ | IL-6, TNF-α, LPS↓ |
| Proteobacteria, Clostridia↓ | IL-10↑ | ||
| Clostridiaceae, Oscillospiraceae, Bifidobacteriaceae↑ | |||
| Lactobacillus, Bifidobacterium↑ | |||
| Lactiplantibacillus plantarum ZDY2013[75] | Actinobacteria (G+) | Lachnospirillaceae, Muribaculaceae, Lactobacillus spp., Alloprevotella and Blautia↑ | LPS/NF-κB↓ |
| Fusobacteria, Verrucomicrobia↓ | Tight binding protein, IR↑ | ||
| Lactobacillus sakei MJM60958[79] | Actinobacteria (G+) | Salmonella gallinarum KCTC 2931, E. coli O1 KCTC 2441, Salmonella cholerae KCTC 2932, Pseudomonas aeruginosa KCCM 11802↓ | Acetic acid↑ |
| Akkermansia mucophila[23] | Verrucomicrobiota (G-) | γδT17, NF-κB, LPS↓ | |
| Fat oxidation, Acetate, IL-10, Mucin (intestinal barrier integrity)↑ | |||
| F. prausnitzii[84,86,87] | Firmicutes (G-) | Erysipelatoclostridium, Faecalibaculum, Blautia, Akkermansia, Bifidobacterium, Lactobacillus, Duboria↑ | TNF-α, IL-1β, IL-6, TLR4↓ |
| Tyzzerella↓ | Butyrate, intestinal barrier↑ | ||
| Christensenella minuta[88] | Firmicutes (G-) | Acetate, butyrate↑ | |
| Bifidobacterium adolescentis[72] | Actinobacteria (G+) | Intestinal barrier↑ | |
| TLR4/NF-κB, IL-6, IL-1β, TNF-α↓ | |||
| Bacteroides ovatus[92] | Bacteroidetes (G-) | Lachnospiraceae_NK4A136_group, norank_f_Oscillospiraceae, Colidextribacterder↑ | SCFA, intestinal barrier↑ |
| F/B, Ruminococcus_torques_group, Ruminococcus_gauvreauii_group, Erysipelothrix rhusiopathiae↓ | LPS, CD163, IL-1β, TNF-α↓ |
- Citation: Shu JZ, Huang YH, He XH, Liu FY, Liang QQ, Yong XT, Xie YF. Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression. World J Hepatol 2025; 17(3): 103854
- URL: https://www.wjgnet.com/1948-5182/full/v17/i3/103854.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i3.103854
